UPDATE: Bank of America Upgrades Seattle Genetics On Trial Risks By: Benzinga via Benzinga May 06, 2014 at 09:06 AM EDT In a report published Tuesday, Bank of America analyst Steve Byrne upgraded the rating on Seattle Genetics (NASDAQ: SGEN) from ... Read More >> Related Stocks: Seagen Inc